While addressing the parliamentarians in the Rajya Sabha on Tuesday, Union Health Minister Dr Harsh Vardhan spoke about the steps taken by the Centre to contain coronavirus spread and said they are using retroviral drugs on some patients for the treatment.
"Scientists at ICMR are in touch with everything happening on this front all over the world. As far as retroviral drugs are concerned, we are using them on some patients. We have got approvals after scientific satisfaction," he said.
"We have heard about some research being done on Chloroquine in the United States right now. Approvals are given after detailed scientific scrutiny, not by Ministry but by scientists working at ICMR. We are trying best to deliver the best possible treatment to the patients," the Union Minister added.
A total of 126 positive cases of coronavirus have been reported in India till Tuesday, the Union Ministry of Health and Family had said in the morning today.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app